MENU
SLXN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Silexion Therapeutics (SLXN) Ownership - Who owns Silexion Therapeutics?

Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for cancers driven by mutations in the mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS)... Show more

Profile

Industry
N/A
Address
12 Abba Hillel Road
Phone
+972 37564999
Employees
14
Web
https://silexion.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.97M
P/E Ratio
0.00
Total Cash
2.23M
Projected Growth
N/A
Total Debt
425K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.40
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
SLXN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
12 Abba Hillel Road
Phone
+972 37564999
Employees
14
Web
https://silexion.com
Who owns Silexion Therapeutics? SLXN symbol Ownership - Tickeron.com